The application of genetically altered mice and tumor cell lines, as well as the application of other CPIs, revealed that this resistance was related to IFN-γ signaling pathway related events, including the upregulation of PD-L1, but also involved other regulatory pathways [107]. The gene discussed is CD274; the disease is neoplasm.